QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

KYTX

QT59Kyverna Therapeutics, Inc.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
8.07
+0.03+0.37%
OverviewShort InterestFilings
KYTXQT59Kyverna Therapeutics, Inc.·NASDAQ
OverviewShort InterestFilings
8.07+0.37%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-
Insider Own18.02%
Shs Outstand60.80M
Perf Week2.54%
Market Cap352.09MForward P/E-EPS next Y-2.94Insider Trans0.00%Shs Float-Perf Month-7.24%
Enterprise Value353.65MPEG-EPS next Q-0.67Inst Own-Short Float-Perf Quarter-5.50%
Income-113336271.00P/S0.00EPS this Y-Inst Trans-Short Ratio-Perf Half Y-21.19%
Sales-P/B2.48EPS next Y-2.66%ROA-60.85%Short Interest-Perf YTD-14.15%
Book/sh3.22P/C-EPS next 5Y-ROE-81.87%52W High13.67 -40.97%Perf Year172.64%
Cash/sh3.88P/FCF-EPS past 3/5Y-ROIC-71.42%52W Low2.52 220.24%Perf 3Y-
Dividend Est.-EV/EBITDA-2.30Sales past 3/5Y-Gross Margin0.00%Volatility4.40% 4.05%Perf 5Y-
Dividend TTM-EV/Sales0.00EPS Y/Y TTM1.50%Oper. Margin0.00%ATR (14)0.53Perf 10Y-
Dividend Ex-Date-Quick Ratio8.15Sales Y/Y TTM-Profit Margin0.00%RSI (14)45.58Recom2.00
Dividend Gr. 3/5Y-Current Ratio8.15EPS Q/Q35.92%SMA20-0.76%Beta2.68Target Price25.00
Payout0.00%Debt/Eq0.17Sales Q/Q-SMA50-9.44%Rel Volume1.46Prev Close8.04
Employees112LT Debt/Eq0.11EarningsAug 11SMA2002.67%Avg Volume1.01MPrice8.07
IPO DateFeb 09, 2024Option/ShortYes / YesEPS/Sales Surpr.12.00% -Net Debt/EBITDA-0.01Volume1,472,142Change0.37%
Analyst Ratings
DateActionAnalystRatingTarget
May-15-26ReiteratedH.C. Wainwright$20 → $25
Dec-16-25ReiteratedWells FargoOverweight$33
Dec-15-25ReiteratedUBS$32
Dec-15-25ReiteratedMorgan StanleyOverweight$25 → $33
Dec-04-25ReiteratedMorgan StanleyOverweight$25
Oct-27-25ReiteratedH.C. Wainwright$10 → $20
Aug-29-25ReiteratedH.C. Wainwright$5.00 → $10
May-27-25UpgradeHC Wainwright & Co.Neutral → Buy
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
Total Revenue000
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A022
Gross Profit0-2-2
Selling, General and Administrative Excl. Other363012
Research and Development13411248
Other Operating Expense0-21
Operating Income-170-143-62
Interest Expense
000
Unusual Expense
———
Non-Operating Income (Expense)-9-15-2
Net Income Before Taxes-161-127-60
Income Taxes
000
Consolidated Net Income-161-127-60
Net Income From Continuing Operations-161-127-60
Net Income-161-127-60
EPS (Recurring)-3.64-3.33-0.00
EPS (Basic, Before Extraordinaries)-3.64-3.33-0.00
EPS (Diluted)-3.64-3.33-0.00
EBITDA-159-125-58
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio
———
Gross Margin———
Operating Margin———
Net Margin———
Shares Outstanding4438674
Market Capitalization414——
Operating Lease Expense
———
Insider Trading Volume
$9.37$8.24$7.12$6.00$4.87● Close Price0.00M0.50M1.00M1.50M2.00MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
SEIDENBERG BETH CDirectorDec 18 '25Buy7.50133,333999,998869,317Dec 22 12:00 AM
Westlake BioPartners Opportunity Fund I, L.P.10% OwnerDec 18 '25Buy7.50133,333999,998869,317Dec 22 12:00 AM
Walker Karen MarieChief Technology OfficerDec 15 '25Option Exercise4.8347,996231,82085,865Dec 17 12:00 AM
Walker Karen MarieChief Technology OfficerDec 15 '25Sale12.2023,998292,77622,636Dec 17 12:00 AM
GILEAD SCIENCES, INC.10% OwnerFeb 12 '24Buy22.00910,00020,020,0004,126,119Feb 13 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR